A Different Approach To Corporate Venture: An Interview With AbbVie Ventures' Scott Brun

10 Jan 2018

AbbVie Ventures is young, but the group was set up with specific goals: to invest specifically in tune with AbbVie's therapeutic focus areas and not to focus purely on return on investment.

Hand holds the magnifying glass in front of an open notebook. Among the many icons, attention is focused on the money icon. Financial operations, banking, lending, etc.

Before launching its own effort less than two years ago, AbbVie Inc. leadership gave significant thought to how it wanted to be different from other biopharma corporate venture arms, according to Scott Brun, a corporate vice president and head of AbbVie Ventures.

Brun moved to AbbVie Ventures after two decades in R&D for AbbVie and its predecessor Abbott Laboratories Inc. He...